{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T22:46:11Z","timestamp":1769121971524,"version":"3.49.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100013642","name":"Japan Heart Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100013642","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Japan Cardiovascular Research Foundation"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-cardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiology"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.jjcc.2012.08.014","type":"journal-article","created":{"date-parts":[[2012,11,17]],"date-time":"2012-11-17T02:01:20Z","timestamp":1353117680000},"page":"58-64","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["The extent of heart rate reduction during hospitalization using beta-blockers, not the achieved heart rate itself at discharge, predicts the clinical outcome in patients with acute heart failure syndromes"],"prefix":"10.1016","volume":"61","author":[{"given":"Hiroyuki","family":"Takahama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Kada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Sekiguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Fujino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Funada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Amaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Asakura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Kanzaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihisa","family":"Anzai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Kitakaze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jjcc.2012.08.014_bib0005","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1056\/NEJMra021498","article-title":"Heart failure","volume":"348","author":"Jessup","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2012.08.014_bib0010","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1161\/01.CIR.103.10.1428","article-title":"Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBISII trial","volume":"103","author":"Lechat","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2012.08.014_bib0015","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/0140-6736(93)92930-R","article-title":"Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy: metoprolol in dilated cardiomyopathy (MDC) Trial Study Group","volume":"342","author":"Waagstein","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.jjcc.2012.08.014_bib0020","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jjcc.2012.02.002","article-title":"Relationship between 24-h Holter recordings and clinical outcomes in patients with permanent atrial fibrillation","volume":"60","author":"Hirano","year":"2012","journal-title":"J Cardiol"},{"key":"10.1016\/j.jjcc.2012.08.014_bib0025","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S0140-6736(10)61259-7","article-title":"SHIFT Investigators. Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomizd placebo-controlled trial","volume":"376","author":"B\u00f6hm","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jjcc.2012.08.014_bib0030","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/0735-1097(95)00332-0","article-title":"Adverse consequence of high sympathetic nervous activity in the failing human heart","volume":"26","author":"Kaye","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2012.08.014_bib0035","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jacc.2009.03.061","article-title":"Symathetic nervous system activation in human heart failure","volume":"54","author":"Floras","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2012.08.014_bib0040","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1161\/01.CIR.94.11.2800","article-title":"Carvedilol inhibits clinical progression in patients with mild symtoms of heart failure, US Carvedilol Heart Failure Study Group","volume":"94","author":"Colucci","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2012.08.014_bib0045","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1161\/CIRCULATIONAHA.105.582320","article-title":"Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence: results of the randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) III","volume":"112","author":"Willenheimer","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2012.08.014_bib0050","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1056\/NEJM197112232852601","article-title":"The natural history of congestive heart failure: the Framingham study","volume":"285","author":"McKee","year":"1971","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2012.08.014_bib0055","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1253\/circj.CJ-08-0130","article-title":"Effects of carperitide on the long-term prognosis of patients with acute decompensated chronic heart failure \u2013 the PROTECT multicenter randomized controlled study","volume":"72","author":"Hata","year":"2008","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2012.08.014_bib0060","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1001\/jama.296.18.2217","article-title":"OPTIMIZE-HF investigators and coordinators. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure","volume":"18","author":"Gheorghiade","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jjcc.2012.08.014_bib0065","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.0006-341X.2005.030814.x","article-title":"Survival model predictive accuracy and ROC curves","volume":"61","author":"Heagerty","year":"2005","journal-title":"Biometrics"},{"key":"10.1016\/j.jjcc.2012.08.014_bib0070","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/0002-9149(71)90439-5","article-title":"Control of myocardial oxygen consumption: physiologic and clinical considerations","volume":"27","author":"Braunwald","year":"1971","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jjcc.2012.08.014_bib0075","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1124\/jpet.103.059717","article-title":"Effects of graded heart rate reduction with ivabradine on myocardial oxygen consumption and diastolic time in exercising dogs","volume":"308","author":"Colin","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jjcc.2012.08.014_bib0080","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1161\/01.RES.41.5.648","article-title":"Effects of maximal coronary vasodilation on transmural myocardial perfusion during tachycardia in the awake dog","volume":"64","author":"Bache","year":"1977","journal-title":"Circ Res"},{"key":"10.1016\/j.jjcc.2012.08.014_bib0085","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1161\/01.CIR.0000018605.14470.DD","article-title":"Carvedilol decreases elevated oxidative stress in human failing myocardium","volume":"24","author":"Nakamura","year":"2002","journal-title":"Circulation"},{"issue":"Suppl.","key":"10.1016\/j.jjcc.2012.08.014_bib0090","first-page":"I77","article-title":"Pathophysiological mechanisms underlying the effects of beta-adrenergic agonists and antagonists on functional capacity and survival in chronic heart failure","volume":"2","author":"Packer","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2012.08.014_bib0095","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.cardiores.2005.02.012","article-title":"Sympathetic neuronal regulation of the heart in aging and heart failure","volume":"66","author":"Kaye","year":"2005","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jjcc.2012.08.014_bib0100","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1161\/01.CIR.0000054164.99881.00","article-title":"Val-HeFT Investigators. Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT)","volume":"107","author":"Anand","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2012.08.014_bib0105","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJM200105313442201","article-title":"Carvedilol prospective randomized cumulative survival study group. Effect of carvedilol on survival in severe chronic heart failure","volume":"344","author":"Packer","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2012.08.014_bib0110","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.1161\/CIRCULATIONAHA.105.590091","article-title":"International working group on acute heart failure syndromes. Acute heart failure syndromes; current state and framework for future research","volume":"112","author":"Gheorghiade","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2012.08.014_bib0115","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1016\/j.jacc.2009.01.075","article-title":"Are BNP changes during hospitalization for heart failure a reliable surrogate for predicting the effects of therapies on post-discharge mortality?","volume":"53","author":"Gheorghiade","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2012.08.014_bib0120","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1161\/01.CIR.85.5.1743","article-title":"Altered myocardial force-frequency relation in human heart failure","volume":"85","author":"Mulieri","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2012.08.014_bib0125","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jjcc.2011.12.006","article-title":"Heart failure as an autonomic nervous system dysfunction","volume":"59","author":"Kishi","year":"2012","journal-title":"J Cardiol"},{"key":"10.1016\/j.jjcc.2012.08.014_bib0130","first-page":"324","article-title":"MUCHA Investigators. Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the multicenter carvedilol heart failure dose assessment (MUCHA) trial","volume":"147","author":"Hori","year":"2004","journal-title":"Am Heart J"}],"container-title":["Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508712002353?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508712002353?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T12:50:58Z","timestamp":1760273458000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0914508712002353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0914508712002353"],"URL":"https:\/\/doi.org\/10.1016\/j.jjcc.2012.08.014","relation":{},"ISSN":["0914-5087"],"issn-type":[{"value":"0914-5087","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The extent of heart rate reduction during hospitalization using beta-blockers, not the achieved heart rate itself at discharge, predicts the clinical outcome in patients with acute heart failure syndromes","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jjcc.2012.08.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}